Showing posts with label trialsitenews. Show all posts
Showing posts with label trialsitenews. Show all posts

Monday, July 12, 2021

Published and Peer Reviewed! the case for IVM (prev post was deleted how?)

 Not sure exactly where my previous post went that I had been linking.. but here is an update:

Ivermectin, majority of test show positive benefit, the data has been published here:

https://trialsitenews.com/news-roundup-uk-based-meta-analysis-on-ivermectin-peer-reviewed-published/

Article 1 | UK-based Meta Analysis Peer Reviewed & Published Suggests Ivermectin A Key Public Health Weapon in the War Against COVID-19:
Recently published in the peer-reviewed American Journal of Therapeutics, Dr. Tess Lawrie, an expert in medicinal evidence, along with other experts in population health and gastroenterology out of the United Kingdom (UK), conducted a comprehensive meta-analysis involving the certainty of evidence using an approach known as GRADE, which led to the focus on twenty-four ivermectin-centered randomized controlled trials involving 3,406 participants.

Article Link | https://trialsitenews.com/uk-based-meta-analysis-peer-reviewed-published-suggests-ivermectin-a-key-public-health-weapon-in-the-war-against-covid-19/

AND here:

https://trialsitenews.com/ivermectin-meta-analysis-evidencing-positive-impact-of-ivermectin-picked-up-by-biospace/

TrialSite calls attention to Alex Keown’s recent article showcasing the recent meta-analysis published in the American Journal of Therapeutics indicating that ivermectin as a potential treatment for COVID-19. Led by well-respected public health advocate Dr. Tess Lawrie, the comprehensive study shows that the generic drug used as an anti-parasitic medicine reduces the risk of death in mild-to-moderate COVID-19 patients by an average of 62%. The study also indicated the risk of death was far lower in those taking ivermectin (2.3%) versus not (7.8%) among hospitalized patients. 

TrialSite commends BioSpace for picking up this critically important story. A well-respected online media focusing on biopharmaceutical drug development, few so-called mainstream media in the health and life science sector picked up this particular news. 

Direct meta analysis link is here:
https://journals.lww.com/americantherapeutics/Fulltext/2021/08000/Ivermectin_for_Prevention_and_Treatment_of.7.aspx

Citation:
Bryant, Andrew MSc1,*; Lawrie, Theresa A. MBBCh, PhD2; Dowswell, Therese PhD2; Fordham, Edmund J. PhD2; Mitchell, Scott MBChB, MRCS3; Hill, Sarah R. PhD1; Tham, Tony C. MD, FRCP4 Ivermectin for Prevention and Treatment of COVID-19 Infection: A Systematic Review, Meta-analysis, and Trial Sequential Analysis to Inform Clinical Guidelines, American Journal of Therapeutics: July/August 2021 - Volume 28 - Issue 4 - p e434-e460

doi: 10.1097/MJT.0000000000001402 

Protocol information and related links and tons more evidence: 
https://covid19criticalcare.com/

Link to all the trials for Ivermectin, HCQ, Fluvoxamine, Vit D, colchicine, etc
https://c19ivermectin.com/   Database of all ivermectin COVID-19 studies. 101 studies, 64 peer reviewed, 62 with results comparing treatment and control groups.

Thursday, June 24, 2021

excess deaths from CDC compared to VAERS database

 Steven is using underreporting value of 5x, but the other leading Dr (whereas steve is more of a business guy) Peter McCollough was using 10x for estimating how much under reporting by VAERS

https://trialsitenews.com/are-the-covid-19-vaccines-safe-and-effective/

the Harvard study in 2010 said it was only reporting 1% , so x 100!



EVERYTHING WRONG WITH THE CAPITAL SHOOTING IN 21 MIN

  https://www.bitchute.com/video/KqK97L60AWAW/